Nutrient Digestion and Body Weight Gain of Balinese Cows Getting Basic Ration of Spear Grass and Rosewood Leaves Supplemented with Falcata Tree Leaves

A study had been conducted to find out nutrient digestion and body weight gain of Balinese cows getting a basic ration of spear grass and Rosewood leaves supplemented with Falcata tree leaves. The study was using complete randomized block design with 4 ration treatments and 3 times repetition. Each repetition was using three Balinese cows. The weights of cows being used were in the range of 83-181 kg. Basic ration being given was arranged based on the percentage of dry ingredients namely: 80% of spear grass + 20% of rosewood leaves (A), 80% of spear grass + 20% of rosewood leaves + 10% of falcata tree leaves (B), 80% of spear grass + 20% of rosewood leaves + 15% of falcata tree leaves (C), and  80% of spear grass + 20% of rosewood leaves + 20% of falcata tree leaves (D), The variables being measured were: nutrient digestion and body weight gain. The result of the study showed that with the administration of 20% falcata tree leaves in the basic ration, it differed significantly (P<0.05) in increasing nutrient digestion and daily weight gain. The result of the study concluded that with the administration of falcata tree leaves in the basic ration of spear grass and rosewood leaves capable to increase nutrient digestion so that bacteria would optimally increase the utilization of fodder and led to a high weight gain of Balinese cows.&nbsp

Psychosocial and Biological Factors Contributing to Body Weight Gain in Schizophrenia

Overweight and obesity are frequently reported to be a significant issue in schizophrenia resulting in the inherent complications of these disorders. Body weight gain also commonly results from treatment with the most tolerable and efficacious pharmacological treatments, second-generation antipsychotics. However there are numerous other factors that contribute to increased body mass in individuals with schizophrenia prior to the initiation of treatment. With prior research indicating that individuals with schizophrenia have higher rates of overweight and obesity before treatment. Therefore this article provides a review of pertinent issues associated with body weight gain in schizophrenia in an attempt to delineate the impact of both the disease and treatment upon body weight gain. The results of the review indicate that body weight gain in schizophrenia occurs from both psychosocial and biological factors that are further compounded by antipsychotic treatment. The article concludes with recommendations for future research

Examining the role of body image, body mass index, body esteem, and perfectionism in anti-fat attitudes : a comparison of gymnasium and non-gymnasium users : a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Psychology at Massey University, Albany, New Zealand

The aim of this study was to examine the interactions between body mass index (BMI), body image, body esteem, perfectionism, and anti-fat attitudes (AFA) within a New Zealand sample of 39 regular gymnasium (gym) users and 33 non-gym users. An online questionnaire was administered to assess BMI, body image, body esteem, perfectionism, and implicit and explicit anti-fat attitudes. Results showed high BMI was associated with greater weight dissatisfaction, regardless of gender or gym use. BMI was positively associated with body and appearance dissatisfaction, but only among non-gym users and females. Regular gym users displayed greater weight preoccupation, overall explicit AFA, and fear of weight gain, compared to non-gym users. Females reported higher appearance, body, and weight dissatisfaction, and lower overall explicit AFA, dislike of overweight individuals, and willpower, compared to males. Implicit and explicit AFA were weakly associated, except among females as implicit AFA significantly correlated with overall explicit AFA and fear of weight gain. A relationship was found between body image and explicit AFA. Specifically, high weight preoccupation correlated with greater overall explicit AFA, regardless of gender or gym use. Furthermore, high appearance and body dissatisfaction and greater weight preoccupation was associated with greater fear of weight gain. Regular gym users high in appearance investment displayed greater fear of weight gain, whereas non-gym users with greater investment in physical appearance reported greater dislike of overweight individuals. Greater weight preoccupation, body and weight dissatisfaction, and investment in physical appearance were associated with greater willpower among men, whereas only weight preoccupation correlated with willpower among women. Body image correlated with implicit AFA, but only among non-gym users and females, such that individuals with high body dissatisfaction and greater weight preoccupation displayed greater implicit AFA. No moderation or mediation effect was found for body esteem on the relationship between body image and AFA. However, perfectionism mediated the effect of body image on AFA. Specifically, maladaptive perfectionism mediated the relationship between Appearance Orientation and overall explicit AFA, Appearance Orientation and Dislike, Appearance Orientation and Fear, Overweight Preoccupation and overall explicit AFA, and Overweight Preoccupation and Fear. Directions for future research and implications within a fitness context are discussed

Does Falling Smoking Lead to Rising Obesity?

The strong negative correlation over time between smoking rates and obesity have led some to suggest that reduced smoking is increasing weight gain in the U.S.. This conclusion is supported by the findings of Chou et al. (2004), who conclude that higher cigarette prices lead to increased body weight. We investigate this issue and find no evidence that reduced smoking leads to weight gain. Using the cigarette tax rather than the cigarette price and controlling for non-linear time effects, we find a negative effect of cigarette taxes on body weight, implying that reduced smoking leads to lower body weights. Yet our results, as well as Chou et al., imply implausibly large effects of smoking on body weight. Thus, we cannot confirm that falling smoking leads in a major way to rising obesity rates in the U.S

Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries

BACKGROUND: In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretroviral therapy should be evaluated. METHODS: Cohort study of 2451 Cambodian and 2618 Kenyan adults who initiated antiretroviral therapy between 2001 and 2007. The prognostic value of weight gain at 3 months of antiretroviral therapy on 3-6 months mortality, and at 6 months on 6-12 months mortality, was investigated using Poisson regression. RESULTS: Mortality rates [95% confidence interval (CI)] between 3 and 6 months of antiretroviral therapy were 9.9 (7.6-12.7) and 13.5 (11.0-16.7) per 100 person-years in Cambodia and Kenya, respectively. At 3 months, among patients with initial body mass index less than or equal to 18.5 kg/m (43% of the study population), mortality rate ratios (95% CI) were 6.3 (3.0-13.1) and 3.4 (1.4-8.3) for those with weight gain less than or equal to 5 and 5-10%, respectively, compared with those with weight gain of more than 10%. At 6 months, weight gain was also predictive of subsequent mortality: mortality rate ratio (95% CI) was 7.3 (4.0-13.3) for those with weight gain less than or equal to 5% compared with those with weight gain of more than 10%. CONCLUSION: Weight gain at 3 months is strongly associated with survival. Poor compliance or undiagnosed opportunistic infections should be investigated in patients with initial body mass index less than or equal to 18.5 and achieving weight gain less than or equal to 10%

Body Image, Self-Esteem, Weight, and Weight Stigma In Male and Female College Students

Emerging adulthood is a developmental period in which college-aged individuals have greater risk for lower self-esteem and more issues with body image. Emerging adulthood is also a time where weight gain is likely to happen and weight is linked to experiences of weight stigma. This study sought to examine the associations between body image, self-esteem, weight, and weight stigma in male and female college students of healthy weight and excess weight. Findings suggest there are strong associations between issues with body image, low self-esteem, and weight stigma among females and males. Further, regardless of weight status, correlations between body image, self-esteem, and weight stigma associations were the same direction and of similar magnitude. Finally, this study found that weight stigma significantly mediated the relationship between body mass index and self-esteem

Associations of Weight Change With Changes in Calf Muscle Characteristics and Functional Decline in Peripheral Artery Disease.

Background Among people with lower extremity peripheral artery disease, obesity is associated with faster functional decline than normal weight. The association of weight loss with functional decline in peripheral artery disease is unknown. Methods and Results Adults with an ankle-brachial index <0.90 were identified from Chicago-area hospitals in 2002-2004. Weight and 6-minute walk distance were measured annually. Weight change categories were weight loss or gain (≥5 pounds/year at ≥1 visit) or stable (weight change <5 pounds at each visit). Participants reported whether weight loss was "intentional" or "unintentional." Calf muscle area was measured with computed tomography every 2 years. Associations of weight change with changes in calf muscle area and 6-minute walk distance were analyzed using mixed-effects models and adjusted for age, body mass index, ankle-brachial index, physical activity, and other confounders. Among 389 participants, mean ankle-brachial index was 0.63±0.16, mean age was 74.5±7.8, and mean body mass index was 28.1±5.1 kg/m2. Over 3.23±1.37 years, muscle area declined more in adults with intentional weight loss versus stable or gain (pair-wise comparisons, P<0.001). Intentional weight loss was associated with less annual decline in 6-minute walk distance than weight gain (intentional loss, 3.7 m; stable, -14.0 m; gain, -28.5 m; unintentional loss, -20.8 m; pair-wise comparison intentional loss versus gain, P=0.003). Conclusions Despite a greater loss of calf muscle area, adults with peripheral artery disease who intentionally lost ≥5 pounds experienced less functional decline than those who gained weight. A randomized trial is needed to establish whether benefits of weight loss in peripheral artery disease outweigh potential adverse effects

Does Falling Smoking Lead to Rising Obesity?

The strong negative correlation over time between smoking rates and obesity have led some to suggest that reduced smoking is increasing weight gain in the U.S.. This conclusion is supported by the findings of Chou et al. (2004), who conclude that higher cigarette prices lead to increased body weight. We investigate this issue and find no evidence that reduced smoking leads to weight gain. Using the cigarette tax rather than the cigarette price and controlling for non-linear time effects, we find a negative effect of cigarette taxes on body weight, implying that reduced smoking leads to lower body weights. Yet our results, as well as Chou et al., imply implausibly large effects of smoking on body weight. Thus, we cannot confirm that falling smoking leads in a major way to rising obesity rates in the U.S.

Effect of adjunctive ranitidine for antipsychotic-induced weight gain: A systematic review of randomized placebo-controlled trials

This study was a meta-analysis of randomized controlled trials (RCTs) of ranitidine as an adjunct for antipsychotic-induced weight gain in patients with schizophrenia. RCTs reporting weight gain or metabolic side effects in patients with schizophrenia were included. Case reports/series, nonrandomized or observational studies, reviews, and meta-analyses were excluded. The primary outcome measures were body mass index (BMI) (kg/m2) and body weight (kg). Four RCTs with five study arms were identified and analyzed. Compared with the control group, adjunctive ranitidine was associated with marginally significant reductions in BMI and body weight. After removing an outlier study for BMI, the effect of ranitidine remained significant. Adjunctive ranitidine outperformed the placebo in the negative symptom score of the Positive and Negative Syndrome Scale. Although ranitidine was associated with less frequent drowsiness, other adverse events were similar between the two groups. Adjunctive ranitidine appears to be an effective an